EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE I

This adverse event was reported 7 times

These drugs are most commonly taken by patients reporting EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE I:

# Drug Count
0 METHOTREXATE SODIUM 3
1 ETANERCEPT 2
2 INTERFERON BETA-1A 2
3 METHOTREXATE 2
4 ALLOPURINOL 1
5 CARBAMAZEPINE 1
6 DIMETHYL FUMARATE 1
7 DULOXETINE 1
8 DULOXETINE HYDROCHLORIDE 1
9 ERGOCALCIFEROL 1
See all common drugs associated with EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE I

EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ERGOCALCIFEROL 1 0.0000
1 CARBAMAZEPINE 1 0.0000
2 DULOXETINE HYDROCHLORIDE 1 0.0000
3 VITAMIN C 1 0.0000
4 INTERFERON BETA-1A 2 0.0000
5 SERTRALINE HYDROCHLORIDE 1 0.0000
6 HYDROCHLOROTHIAZIDE 1 0.0000
7 ALLOPURINOL 1 0.0000
8 METHOTREXATE SODIUM 3 0.0000
9 LOSARTAN 1 0.0000
See all drugs enriched for association with EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE I

EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE I is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 1 0.0000
1 Interferon beta [EPC] 2 0.0000
2 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
3 Thiazide Diuretic [EPC] 1 0.0000
4 Mood Stabilizer [EPC] 1 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
6 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
7 Vitamin C [EPC] 1 0.0000
8 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
9 Proton Pump Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE I